#drugsafety

  1. EMA's Battle Against Falsified Drugs in the Supply Chain

    By EMA's Battle Against Falsified Drugs in the Supply Chain - PharmaShots Introduction The pharmaceutical industry plays a critical role in global public health by ensuring the safety and efficacy of drugs. The European Medicines Agency (EMA) is tasked with safeguarding the
  2. Police urgent warning over 'stronger drugs' after four deaths in last month

    By Jonathan Coles & Zahra Khaliq Police are warning of a potentially fatal batch of drugs that they fear is circulating after it was linked to four deaths in a month. Wiltshire Police have turned their attention to a new group of drugs called nitazenes, which pose a substantial ris
  3. Doctor's warning to anyone in UK regularly taking painkillers

    By Charlotte Smith & Rom Preston-Ellis Many people have a daily routine of taking paracetamol - whether it's to soothe a headache before bed, mask period pains or prevent a hangover the next morning. However, medics have issued a stark warning to those who exceed the recommended da
  4. Zantac not a cause of woman’s cancer, jury says in first trial over drug

    By: Diana Novak Jones CHICAGO (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations. The jury in Cook County, I
  5. Sanofi Highlights Data from P-II Trial of Rilzabrutinib to Treat Moderate-to-Severe Asthma at ATS 2024

    By PharmaShots Shots: The P-II PoC trial evaluates rilzabrutinib's (800mg & 1200mg, QD) safety, efficacy & tolerability vs PBO added to ICS/LABA background therapy for treating moderate-to-severe asthma patients not controlled on ICS plus LABA therapy The study depicted a 36% (hig
  6. White Powder Found In The White House Confirmed To Be Cocaine #whitehouse #government #drugsafety #SecretService
  7. 📢 Major news from Ensysce Biosciences, Inc. (NASDAQ:ENSC) 🎉 They've successfully completed the clinical study of PF614-MPAR, a first-of-its-kind pain med with overdose protection. This revolutionary drug can limit opioid exposure when an excessive number of pills are consumed, o